References
- Wang H, Chai K, Du M, Wang S, Cai JP, Li Y, et al. Prevalence and incidence of heart failure among urban patients in China: A national population-based analysis. Circ Heart Fail. 2021;14(10):
e008406 . DOI: 10.1161/CIRCHEARTFAILURE.121.008406 - Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022;145(18):e895–e1032. DOI: 10.1161/CIR.0000000000001063
- Averina M, Stylidis M, Brox J, Schirmer H. NT-ProBNP and high-sensitivity troponin T as screening tests for subclinical chronic heart failure in a general population. ESC Heart Fail. 2022;9(3):1954–1962. DOI: 10.1002/ehf2.13906
- Adabifirouzjaei F, Kimura BJ, Khazai B, DeMaria AN. Handheld ultrasonography in cardiovascular medicine, updates and controversies. Prog Cardiovasc Dis. 2022;74:70–79. DOI: 10.1016/j.pcad.2022.10.012
- The Writing Committee Of The Report On Cardiovascular Health And Diseases In China, Hu SS. Report on cardiovascular health and diseases in China 2021: An updated summary. J Geriatr Cardiol. 2023;20(6):399–430. DOI: 10.26599/1671-5411.2023.06.001
- Li X, Krumholz HM, Yip W, Cheng KK, De Maeseneer J, et al. Quality of primary health care in China: Challenges and recommendations. Lancet. 2020;395(10239):1802–1812. DOI: 10.1016/S0140-6736(20)30122-7
- Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019;32(1):1–64. DOI: 10.1016/j.echo.2018.06.004
- Mercaldo ND, Lau KF, Zhou XH. Confidence intervals for predictive values with an emphasis to case-control studies. Stat Med. 2007;26(10):2170–2183. DOI: 10.1002/sim.2677
- Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC, et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation. 2007;115(12):1563–1570. DOI: 10.1161/CIRCULATIONAHA.106.666818
- Shah AM, Claggett B, Loehr LR, Chang PP, Matsushita, K, Kitzman D, et al. Heart failure stages among older adults in the community: The Atherosclerosis Risk in Communities Study. Circulation. 2017;135(3):224–240. DOI: 10.1161/CIRCULATIONAHA.116.023361
- Vasan RS, Musani SK, Matsushita K, Beard W, Obafemi OB, Butler KR, et al. Epidemiology of heart failure stages in middle-aged black people in the community: Prevalence and Prognosis in the Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2021;10(9):
e016524 . DOI: 10.1161/JAHA.120.016524 - Xanthakis V, Enserro DM, Larson MG, Wollert KC, Januzzi JL, Levy D, et al. Prevalence, neurohormonal correlates, and prognosis of heart failure stages in the community. JACC Heart Fail. 2016;4(10):808–815. DOI: 10.1016/j.jchf.2016.05.001
- Parveen S, Zareini B, Arulmurugananthavadivel A, Kistorp C, Faber J, Køber L, et al. Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study). BMC Geriatr. 2022;22(1):
230 . DOI: 10.1186/s12877-022-02875-1 - Nambi V, Deswal A, Ballantyne CM. Prevention of “failure”: Is it a failure of prevention? Circulation. 2018;137(2):106–108. DOI: 10.1161/CIRCULATIONAHA.117.030645
- Ledwidge M, Gallagher J, Conlon C, Tallon E, O’Connell E, Dawkins I, et al. Natriuretic peptide-based screening and collaborative care for heart failure: The STOP-HF Randomized Trial. JAMA. 2013;310(1):66–74. DOI: 10.1001/jama.2013.7588
- Wright AK, Carr MJ, Kontopantelis E, Leelarathna L, Thabit H, Emsley R, et al. Primary prevention of cardiovascular and heart failure events with SGLT2 inhibitors, GLP-1 receptor agonists, and their combination in type 2 diabetes. Diabetes Care. 2022;45(4):909–918. DOI: 10.2337/dc21-1113
- Vasan RS, Urbina EM, Jin L, Xanthakis V. Prognostic significance of echocardiographic measures of cardiac remodeling in the community. Curr Cardiol Rep. 2021;23(7):
86 . DOI: 10.1007/s11886-021-01512-4 - Ghany R, Tamariz L, Chen G, Ghany A, Forbes E, Tajiri T, et al. Screening echocardiograms in a senior focused value based primary care improves systolic heart failure detection and clinical management. Cardiovasc Diagn Ther. 2017;7(3):236–243. DOI: 10.21037/cdt.2017.03.09
- Galasko GI, Lahiri A, Senior R. Portable echocardiography: An innovative tool in screening for cardiac abnormalities in the community. Eur J Echocardiogr. 2003;4(2):119–127. DOI: 10.1053/euje.2002.0627
- Yang H, Negishi K, Wang Y, Nolan M, Saito M, Marwick TH. Echocardiographic screening for non-ischaemic stage B heart failure in the community. Eur J Heart Fail. 2016;18(11):1331–1339. DOI: 10.1002/ejhf.643
- Wang Y, Yang H, Huynh Q, Nolan M, Negishi K, Marwick TH. Diagnosis of nonischemic stage B heart failure in type 2 diabetes mellitus: Optimal parameters for prediction of heart failure. JACC Cardiovasc Imaging. 2018;11(10):1390–1400. DOI: 10.1016/j.jcmg.2018.03.015
- Nascimento BR, Beaton AZ, Pereira Nunes MC, Tompsett AR, Oliveira KBK, Diamantino AC, et al. Integration of echocardiographic screening by non-physicians with remote reading in primary care. Heart. 2019;105(4):283–290. DOI: 10.1136/heartjnl-2018-313593
- Magelssen MI, Palmer CL, Hjorth-Hansen A, Nilsen HO, Kiss G, Torp H, et al. Feasibility and reliability of automatic quantitative analyses of mitral annular plane systolic excursion by handheld ultrasound devices: A pilot study. J Ultrasound Med. 2021;40(2):341–350. DOI: 10.1002/jum.15408
- Nakamura M, Tanaka F, Yonezawa S, Satou K, Nagano M, Hiramori K. The limited value of plasma B-type natriuretic peptide for screening for left ventricular hypertrophy among hypertensive patients. Am J Hypertens. 2003;16(12):1025–1029. DOI: 10.1016/j.amjhyper.2003.07.024
- Somaratne JB, Whalley GA, Poppe KK, ter Bals MM, Wadams G, Pearl A, et al. Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community. Cardiovasc Diabetol. 2011;10:
29 . DOI: 10.1186/1475-2840-10-29 - Mureddu GF, Tarantini L, Agabiti N, Faggiano P, Masson S, Latini R, et al. Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre-clinical (stage B) heart failure in the elderly. Results from ‘PREDICTOR’, a population based-study in central Italy. Eur J Heart Fail. 2013;15(10):1102–1112. DOI: 10.1093/eurjhf/hft098